Pouneh Fazeli, MD, MPH, named Chief of the Division of Endocrinology and Metabolism
April 1, 2025
This announcement was originally posted by the University of Pittsburgh Department of Medicine.
Pouneh K. Fazeli, MD, MPH, has been appointed as the new Chief of the Division of Endocrinology and Metabolism in the Department of Medicine, effective April 1, 2025. This follows an extensive national search process. Dr. Fazeli is currently an Associate Professor of Medicine, the Director of the Neuroendocrinology Unit, and the Medical Director of the Pituitary Center of Excellence at UPMC. She also serves as Chief of the Division of Endocrinology at the VA Pittsburgh Healthcare System.
Dr. Fazeli earned her undergraduate degree from Harvard University, her medical degree from the University of Pennsylvania School of Medicine, and an MPH from the Harvard School of Public Health. She completed her internal medicine residency at Columbia University Medical Center, where she also served as Chief Resident. Dr. Fazeli went on to complete her fellowship training in Endocrinology at Massachusetts General Hospital, where she was appointed attending physician in the Neuroendocrine Unit and Associate Program Director of the MGH Endocrinology Fellowship Training Program. She was recruited to the University of Pittsburgh and UPMC in 2019.
As a clinical and translational researcher, Dr. Fazeli has a primary focus on understanding neuroendocrine adaptations to undernutrition and intermittent fasting. Her research has explored hormonal adaptations leading to profound bone loss in women with anorexia nervosa. She currently leads NIH-funded clinical studies investigating therapies for bone loss in women with anorexia nervosa, as well as the effects of intermittent fasting on metabolic and bone health. As Director of the Neuroendocrinology Unit, Dr. Fazeli established the inpatient neuroendocrine service and serves as the founding Medical Director of the internationally recognized Pituitary Center of Excellence at UPMC. In this role, she is also the site PI for multiple studies examining medical therapies for Cushing’s syndrome and acromegaly.
Please join us in welcoming Dr. Fazeli as the new Chief of the Division of Endocrinology and Metabolism. We are excited about the continued growth and success of the Division under her leadership.
